Skip to main content
Top
Published in: Internal and Emergency Medicine 5/2018

01-08-2018 | EM - ORIGINAL

Myocardial dysfunction after out-of-hospital cardiac arrest: predictors and prognostic implications

Authors: Yuan Yao, Nicholas James Johnson, Sarah Muirhead Perman, Vimal Ramjee, Anne Victoria Grossestreuer, David Foster Gaieski

Published in: Internal and Emergency Medicine | Issue 5/2018

Login to get access

Abstract

We aim to determine the incidence of early myocardial dysfunction after out-of-hospital cardiac arrest, risk factors associated with its development, and association with outcome. A retrospective chart review was performed among consecutive out-of-hospital cardiac arrest (OHCA) patients who underwent echocardiography within 24 h of return of spontaneous circulation at three urban teaching hospitals. Our primary outcome is early myocardial dysfunction, defined as a left ventricular ejection fraction < 40% on initial echocardiogram. We also determine risk factors associated with myocardial dysfunction using multivariate analysis, and examine its association with survival and neurologic outcome. A total of 190 patients achieved ROSC and underwent echocardiography within 24 h. Of these, 83 (44%) patients had myocardial dysfunction. A total of 37 (45%) patients with myocardial dysfunction survived to discharge, 39% with intact neurologic status. History of congestive heart failure (OR 6.21; 95% CI 2.54–15.19), male gender (OR 2.27; 95% CI 1.08–4.78), witnessed arrest (OR 4.20; 95% CI 1.78–9.93), more than three doses of epinephrine (OR 6.10; 95% CI 1.12–33.14), more than four defibrillations (OR 4.7; 95% CI 1.35–16.43), longer duration of resuscitation (OR 1.06; 95% CI 1.01–1.10), and therapeutic hypothermia (OR 3.93; 95% CI 1.32–11.75) were associated with myocardial dysfunction. Cardiopulmonary resuscitation immediately initiated by healthcare personnel was associated with lower odds of myocardial dysfunction (OR 0.40; 95% CI 0.17–0.97). There was no association between early myocardial dysfunction and mortality or neurological outcome. Nearly half of OHCA patients have myocardial dysfunction. A number of clinical factors are associated with myocardial dysfunction, and may aid providers in anticipating which patients need early diagnostic evaluation and specific treatments. Early myocardial dysfunction is not associated with neurologically intact survival.
Literature
1.
go back to reference Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123(4):e18–e209CrossRef Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123(4):e18–e209CrossRef
2.
go back to reference Nichol G, Rumsfeld J, Eigel B et al (2008) Essential features of designating out-of-hospital cardiac arrest as a reportable event: a scientific statement from the American Heart Association Emergency Cardiovascular Care Committee; Council on Cardiopulmonary, Perioperative, and Critical Care; Council on Cardiovascular Nursing; Council on Clinical Cardiology; and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 117(17):2299–2308CrossRefPubMed Nichol G, Rumsfeld J, Eigel B et al (2008) Essential features of designating out-of-hospital cardiac arrest as a reportable event: a scientific statement from the American Heart Association Emergency Cardiovascular Care Committee; Council on Cardiopulmonary, Perioperative, and Critical Care; Council on Cardiovascular Nursing; Council on Clinical Cardiology; and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 117(17):2299–2308CrossRefPubMed
3.
go back to reference Nolan JP, Neumar RW, Adrie C et al (2008) Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. Resuscitation 79(3):350–379CrossRefPubMed Nolan JP, Neumar RW, Adrie C et al (2008) Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. Resuscitation 79(3):350–379CrossRefPubMed
4.
go back to reference Laurent I, Monchi M, Chiche JD et al (2002) Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 40(12):2110–2116CrossRefPubMed Laurent I, Monchi M, Chiche JD et al (2002) Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 40(12):2110–2116CrossRefPubMed
5.
go back to reference Ruiz-Bailen M, Aguayo de Hoyos E, Ruiz-Navarro S et al (2005) Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation 66(2):175–181CrossRefPubMed Ruiz-Bailen M, Aguayo de Hoyos E, Ruiz-Navarro S et al (2005) Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation 66(2):175–181CrossRefPubMed
6.
go back to reference Kloner RA, Jennings RB (2001) Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 104(24):2981–2989CrossRefPubMed Kloner RA, Jennings RB (2001) Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 104(24):2981–2989CrossRefPubMed
7.
go back to reference Kern KB, Hilwig RW, Rhee KH et al (1996) Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 28(1):232–240CrossRefPubMed Kern KB, Hilwig RW, Rhee KH et al (1996) Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 28(1):232–240CrossRefPubMed
9.
go back to reference Leary M, Grossestreuer AV, Iannacone S et al (2013) Pyrexia and neurologic outcomes after therapeutic hypothermia for cardiac arrest. Resuscitation 84(8):1056–1061CrossRefPubMed Leary M, Grossestreuer AV, Iannacone S et al (2013) Pyrexia and neurologic outcomes after therapeutic hypothermia for cardiac arrest. Resuscitation 84(8):1056–1061CrossRefPubMed
10.
go back to reference Grossestreuer AV, Abella BS, Leary M, Perman SM, Fuchs BD, Kolansky DM, Beylin ME, Gaieski DF (2013) Time to awakening and neurologic outcome in therapeutic hypothermia-treated cardiac arrest patients. Resuscitation 84(12):1741–1746CrossRefPubMed Grossestreuer AV, Abella BS, Leary M, Perman SM, Fuchs BD, Kolansky DM, Beylin ME, Gaieski DF (2013) Time to awakening and neurologic outcome in therapeutic hypothermia-treated cardiac arrest patients. Resuscitation 84(12):1741–1746CrossRefPubMed
11.
go back to reference Lindenfeld J, Albert NM, Boehmer JP et al (2010) HFSA 2010 comprehensive heart failure practice guideline. J Cardiac Fail 16(6):e1–e194CrossRef Lindenfeld J, Albert NM, Boehmer JP et al (2010) HFSA 2010 comprehensive heart failure practice guideline. J Cardiac Fail 16(6):e1–e194CrossRef
13.
go back to reference Deantonio HJ, Kaul S, Lerman BB (1990) Reversible myocardial depression in survivors of cardiac arrest. Pacing Clin Electrophysiol PACE 13(8):982–985CrossRefPubMed Deantonio HJ, Kaul S, Lerman BB (1990) Reversible myocardial depression in survivors of cardiac arrest. Pacing Clin Electrophysiol PACE 13(8):982–985CrossRefPubMed
14.
go back to reference Chang WT, Ma MH, Chien KL et al (2007) Postresuscitation myocardial dysfunction: correlated factors and prognostic implications. Intensive Care Med 33(1):88–95CrossRefPubMed Chang WT, Ma MH, Chien KL et al (2007) Postresuscitation myocardial dysfunction: correlated factors and prognostic implications. Intensive Care Med 33(1):88–95CrossRefPubMed
15.
go back to reference Tak Boland TA, Lee VH, Bleck TP (2015) Stress-induced cardiomyopathy. Crit Care Med 43(3):686–693CrossRef Tak Boland TA, Lee VH, Bleck TP (2015) Stress-induced cardiomyopathy. Crit Care Med 43(3):686–693CrossRef
16.
go back to reference Wybraniec MT, Mizia-Stec K, Krzych Ł (2014) Neurocardiogenic injury in subarachnoid hemorrhage: a wide spectrum of catecholamine-mediated brain–heart interactions. Cardiol J 21(3):220–228CrossRefPubMed Wybraniec MT, Mizia-Stec K, Krzych Ł (2014) Neurocardiogenic injury in subarachnoid hemorrhage: a wide spectrum of catecholamine-mediated brain–heart interactions. Cardiol J 21(3):220–228CrossRefPubMed
17.
go back to reference Yamaguchi H, Weil M, Tang W et al (2002) Myocardial dysfunction after electrical defibrillation. Resuscitation 54(3):289–296CrossRefPubMed Yamaguchi H, Weil M, Tang W et al (2002) Myocardial dysfunction after electrical defibrillation. Resuscitation 54(3):289–296CrossRefPubMed
18.
go back to reference Caterine MR, Spencer KT, Pagan-Carlo LA et al (1996) Direct current shocks to the heart generate free radicals: an electron paramagnetic resonance study. J Am Coll Cardiol 28(6):1598–1609CrossRefPubMed Caterine MR, Spencer KT, Pagan-Carlo LA et al (1996) Direct current shocks to the heart generate free radicals: an electron paramagnetic resonance study. J Am Coll Cardiol 28(6):1598–1609CrossRefPubMed
19.
go back to reference Zaugg CE, Ziegler A, Lee RJ et al (2002) Postresuscitation stunning: postfibrillatory myocardial dysfunction caused by reduced myofilament Ca2+ responsiveness after ventricular fibrillation-induced myocyte Ca2+ overload. J Cardiovasc Electrophysiol 13(10):1017–1024CrossRefPubMed Zaugg CE, Ziegler A, Lee RJ et al (2002) Postresuscitation stunning: postfibrillatory myocardial dysfunction caused by reduced myofilament Ca2+ responsiveness after ventricular fibrillation-induced myocyte Ca2+ overload. J Cardiovasc Electrophysiol 13(10):1017–1024CrossRefPubMed
20.
go back to reference Chalkias A, Xanthos T (2012) Pathophysiology and pathogenesis of post-resuscitation myocardial stunning. Heart Fail Rev 17(1):117–128CrossRefPubMed Chalkias A, Xanthos T (2012) Pathophysiology and pathogenesis of post-resuscitation myocardial stunning. Heart Fail Rev 17(1):117–128CrossRefPubMed
21.
go back to reference Vukmir RB, Sodium Bicarbonate Study Group (2004) Witnessed arrest, but not delayed bystander cardiopulmonary resuscitation improves prehospital cardiac arrest survival. Emerg Med J 21(3):370–373CrossRefPubMedPubMedCentral Vukmir RB, Sodium Bicarbonate Study Group (2004) Witnessed arrest, but not delayed bystander cardiopulmonary resuscitation improves prehospital cardiac arrest survival. Emerg Med J 21(3):370–373CrossRefPubMedPubMedCentral
22.
go back to reference Engdahl J, Bang A, Karlson BW et al (2003) Characteristics and outcome among patients suffering from out of hospital cardiac arrest of non-cardiac aetiology. Resuscitation 57(1):33–41CrossRefPubMed Engdahl J, Bang A, Karlson BW et al (2003) Characteristics and outcome among patients suffering from out of hospital cardiac arrest of non-cardiac aetiology. Resuscitation 57(1):33–41CrossRefPubMed
23.
go back to reference Callaway CW, Donnino MW, Fink EL et al (2015) Part 8: post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 3(132):S465–S482CrossRef Callaway CW, Donnino MW, Fink EL et al (2015) Part 8: post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 3(132):S465–S482CrossRef
24.
go back to reference Mottillo S, Sharma K, Eisenberg MJ (2011) Therapeutic hypothermia in acute myocardial infarction: a systematic review. Can J Cardiol 27(5):555–561CrossRefPubMed Mottillo S, Sharma K, Eisenberg MJ (2011) Therapeutic hypothermia in acute myocardial infarction: a systematic review. Can J Cardiol 27(5):555–561CrossRefPubMed
25.
go back to reference Zobel C, Adler C, Kranz A et al (2012) Mild therapeutic hypothermia in cardiogenic shock syndrome. Crit Care Med 40(6):1715–1723CrossRefPubMed Zobel C, Adler C, Kranz A et al (2012) Mild therapeutic hypothermia in cardiogenic shock syndrome. Crit Care Med 40(6):1715–1723CrossRefPubMed
26.
go back to reference Hsu CY, Huang CH, Chang WT et al (2009) Cardioprotective effect of therapeutic hypothermia for postresuscitation myocardial dysfunction. Shock (Augusta, Ga.) 32(2):210–216CrossRef Hsu CY, Huang CH, Chang WT et al (2009) Cardioprotective effect of therapeutic hypothermia for postresuscitation myocardial dysfunction. Shock (Augusta, Ga.) 32(2):210–216CrossRef
27.
go back to reference Chenoune M, Lidouren F, Adam C et al (2011) Ultrafast and whole-body cooling with total liquid ventilation induces favorable neurological and cardiac outcomes after cardiac arrest in rabbits. Circulation 124(8):901–911CrossRefPubMedPubMedCentral Chenoune M, Lidouren F, Adam C et al (2011) Ultrafast and whole-body cooling with total liquid ventilation induces favorable neurological and cardiac outcomes after cardiac arrest in rabbits. Circulation 124(8):901–911CrossRefPubMedPubMedCentral
28.
go back to reference Gotberg M, van der Pals J, Olivecrona GK et al (2010) Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model. Resuscitation 81(9):1190–1196CrossRefPubMed Gotberg M, van der Pals J, Olivecrona GK et al (2010) Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model. Resuscitation 81(9):1190–1196CrossRefPubMed
29.
go back to reference Meybohm P, Gruenewald M, Albrecht M et al (2009) Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling. PLoS One 4(10):e7588CrossRefPubMedPubMedCentral Meybohm P, Gruenewald M, Albrecht M et al (2009) Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling. PLoS One 4(10):e7588CrossRefPubMedPubMedCentral
30.
go back to reference Maeng M, Mortensen UM, Kristensen J, Kristiansen SB, Andersen HR (2006) Hypothermia during reperfusion does not reduce myocardial infarct size in pigs. Basic Res Cardiol 101(1):61–68CrossRefPubMed Maeng M, Mortensen UM, Kristensen J, Kristiansen SB, Andersen HR (2006) Hypothermia during reperfusion does not reduce myocardial infarct size in pigs. Basic Res Cardiol 101(1):61–68CrossRefPubMed
31.
go back to reference Bro-Jeppesen J, Hassager C, Wanscher M et al (2014) Targeted temperature management at 33 vs 36 °C and impact on systemic vascular resistance and myocardial function after out-of-hospital cardiac arrest: a sub-study of the target temperature management trial. Circ Cardiovasc Interv 7(5):663–672CrossRefPubMed Bro-Jeppesen J, Hassager C, Wanscher M et al (2014) Targeted temperature management at 33 vs 36 °C and impact on systemic vascular resistance and myocardial function after out-of-hospital cardiac arrest: a sub-study of the target temperature management trial. Circ Cardiovasc Interv 7(5):663–672CrossRefPubMed
32.
go back to reference Polderman KH (2009) Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 37(7 Suppl):S186–S202CrossRefPubMed Polderman KH (2009) Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 37(7 Suppl):S186–S202CrossRefPubMed
33.
go back to reference El-Menyar AA (2004) Postresuscitation myocardial stunning and its outcome: new approaches. Crit Pathw Cardiol 3(4):209–215PubMed El-Menyar AA (2004) Postresuscitation myocardial stunning and its outcome: new approaches. Crit Pathw Cardiol 3(4):209–215PubMed
34.
go back to reference Nielsen N, Wetterslev J, Cronberg T et al (2013) Targeted temperature management at 33 vs 36 °C after cardiac arrest. N Engl J Med 369(23):2197–2206CrossRefPubMed Nielsen N, Wetterslev J, Cronberg T et al (2013) Targeted temperature management at 33 vs 36 °C after cardiac arrest. N Engl J Med 369(23):2197–2206CrossRefPubMed
35.
go back to reference Gaieski DF, Band RA, Abella BS et al (2009) Early goal-directed hemodynamic optimization combined with therapeutic hypothermia in comatose survivors of out-of-hospital cardiac arrest. Resuscitation 80(4):418–424CrossRefPubMed Gaieski DF, Band RA, Abella BS et al (2009) Early goal-directed hemodynamic optimization combined with therapeutic hypothermia in comatose survivors of out-of-hospital cardiac arrest. Resuscitation 80(4):418–424CrossRefPubMed
36.
go back to reference Bougouin W, Cariou A (2013) Management of postcardiac arrest myocardial dysfunction. Curr Opin Crit Care 19(3):195–201CrossRefPubMed Bougouin W, Cariou A (2013) Management of postcardiac arrest myocardial dysfunction. Curr Opin Crit Care 19(3):195–201CrossRefPubMed
37.
go back to reference Hovdenes J, Laake JH, Aaberge L et al (2007) Therapeutic hypothermia after out-of-hospital cardiac arrest: experiences with patients treated with percutaneous coronary intervention and cardiogenic shock. Acta Anaesthesiol Scand 51(2):137–142CrossRefPubMed Hovdenes J, Laake JH, Aaberge L et al (2007) Therapeutic hypothermia after out-of-hospital cardiac arrest: experiences with patients treated with percutaneous coronary intervention and cardiogenic shock. Acta Anaesthesiol Scand 51(2):137–142CrossRefPubMed
38.
go back to reference Gonzalez MM, Berg RA, Nadkarni VM, Vianna CB, Kern KB, Timerman S, Ramires JA (2008) Left ventricular systolic function and outcome after in-hospital cardiac arrest. Circulation 117(14):1864–1872CrossRefPubMed Gonzalez MM, Berg RA, Nadkarni VM, Vianna CB, Kern KB, Timerman S, Ramires JA (2008) Left ventricular systolic function and outcome after in-hospital cardiac arrest. Circulation 117(14):1864–1872CrossRefPubMed
Metadata
Title
Myocardial dysfunction after out-of-hospital cardiac arrest: predictors and prognostic implications
Authors
Yuan Yao
Nicholas James Johnson
Sarah Muirhead Perman
Vimal Ramjee
Anne Victoria Grossestreuer
David Foster Gaieski
Publication date
01-08-2018
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 5/2018
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1756-z

Other articles of this Issue 5/2018

Internal and Emergency Medicine 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine